GET THE APP

..

Nuclear Medicine & Radiation Therapy

ISSN: 2155-9619

Open Access

Arcangeli S


Italy

Publications
  • Review Article
    Malignant Pleural Mesothelioma: Management and Role of Radiation Therapy
    Author(s): Donato V, Dognini J, Arcangeli S, Melis E and Facciolo FDonato V, Dognini J, Arcangeli S, Melis E and Facciolo F

    Malignant pleural mesothelioma is a neoplasm derived from the mesothelial surfaces of the pleura. There are tree different mesothelioma types: Epithelioid Mesothelioma; Sarcomatoid; Biphasic /Mixed Mesothelioma. Patients with mesothelioma have a poor prognosis with a median survival ranging from 6 to 18 months depending on the stage of the disease at the time of diagnosis. Standard Management: For patients with clinical stage I-III and Epithelial or Mixed histology who are considered medically fit, surgery is recommended with extrapleural pnemonectomy (EPP) or pleurectomy/decortication (P/D). Adjuvant radiation therapy is recommended for patients with good performance status: the goal of adjuvant radiotherapy is to improve local control and it is an effective palliative treatment for relief of chest pain associated with meso.. Read More»
    DOI: 10.4172/2155-9619.S2-011

    Abstract PDF

Relevant Topics

Google Scholar citation report
Citations: 706

Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report

Nuclear Medicine & Radiation Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward